| Literature DB >> 32717378 |
Arsia Jamali1, Brendan Kenyon2, Gustavo Ortiz1, Abdo Abou-Slaybi3, Victor G Sendra1, Deshea L Harris1, Pedram Hamrah4.
Abstract
Plasmacytoid dendritic cells (pDCs) are a unique subpopulation of immune cells, distinct from classical dendritic cells. pDCs are generated in the bone marrow and following development, they typically home to secondary lymphoid tissues. While peripheral tissues are generally devoid of pDCs during steady state, few tissues, including the lung, kidney, vagina, and in particular ocular tissues harbor resident pDCs. pDCs were originally appreciated for their potential to produce large quantities of type I interferons in viral immunity. Subsequent studies have now unraveled their pivotal role in mediating immune responses, in particular in the induction of tolerance. In this review, we summarize our current knowledge on pDCs in ocular tissues in both mice and humans, in particular in the cornea, limbus, conjunctiva, choroid, retina, and lacrimal gland. Further, we will review our current understanding on the significance of pDCs in ameliorating inflammatory responses during herpes simplex virus keratitis, sterile inflammation, and corneal transplantation. Moreover, we describe their novel and pivotal neuroprotective role, their key function in preserving corneal angiogenic privilege, as well as their potential application as a cell-based therapy for ocular diseases.Entities:
Keywords: Angiogenesis; Neuroprotection; Plasmacytoid dendritic cells; Tolerance; Transplantation; Viral keratitis
Mesh:
Year: 2020 PMID: 32717378 PMCID: PMC7854822 DOI: 10.1016/j.preteyeres.2020.100877
Source DB: PubMed Journal: Prog Retin Eye Res ISSN: 1350-9462 Impact factor: 21.198